Business, Free News Articles, NonProfit and Charities, Regional Events

COVID Variants Do Not Stop C. diff. Awareness Walks Worldwide

TEANECK, N.J. -- C Diff Foundation announced today that the 5th Annual Global C. diff. Awareness Walks will take place on-demand, on a livestream, and in-person at Sims Park, New Port Richey, FL, and Brown Street Park Complex, Spring city, PA, and Milton A. Votee, Teaneck, NJ. This year's annual events will take place on Saturday, September 25, 2021, from 9 a.m. - 12 p.m. EDT. Learn more at: https://www.cdiffwalks.com

Proceeds from the events will benefit the C Diff Foundation's mission educating and advocating for C. difficile infection prevention, treatments, clinical trials, and environmental safety worldwide. During these unprecedented times the C Diff Foundation effectively adapts to overcome the many obstacles developing from this global virus and the variants of SARS-CoV-2 that have been emerging and circulating around the world throughout the COVID-19 pandemic.

C. diff. infections are one of the leading healthcare-associated infections facing local communities worldwide. According to the Centers for Disease Control and Prevention (CDC), a Clostridioides difficile infection (C. diff., C. difficile), (formally known as Clostridium difficile) "has become the most common microbial cause of healthcare-associated infections in U.S. hospitals and costs up to $4.8 billion each year in excess health care costs for acute care facilities alone." Statistics provided by the CDC suggest that C. difficile cause nearly 500,000 infections in patients in the U.S. annually. In one study noted by the CDC, among infected patients, nearly 29,000 died within 30 days of being diagnosed, and more than half of those deaths (15,000) were directly attributable to a C. difficile infection.

"C Diff Foundation volunteering members have a passion to improve the lives of patients, families, and caregivers who have been impacted by C. diff. infections worldwide," says Nancy C. Caralla, Founding President, Executive Director of the C Diff Foundation. "At the in-person C. diff. Awareness Walks, a safe distance will be maintained, and hand sanitizer will be available to ensure a safe outdoor event. 'Let's Walk' presents educational information shared by health care professionals, and C. diff. Survivors, through on-demand walks and livestream options located on the dedicated event website: https://cdiffwalks.com."

Thank you, Ferring Pharmaceuticals, for being the Global Sponsor of the 5th Annual Global C. diff. Awareness Walks. Ferring Pharmaceuticals is a research-driven, specialty biopharmaceutical group committed to helping people around the world build families and live better lives. Ferring is a leader in reproductive medicine and maternal health, and in specialty areas within gastroenterology and urology. Ferring is committed to exploring the crucial link between the microbiome and human health, beginning with the threat of recurrent C. difficile infection. With the 2018 acquisition of Rebiotix and several other alliances, Ferring is a world leader in microbiome research, developing novel microbiome-based therapeutics to address significant unmet needs and help people live better lives. For more information visit https://www.ferringusa.com.

We also extend our thanks to Seres Therapeutics, Inc. for being the Diamond Sponsor of the 5th Annual Global C. diff. Awareness Walks.

Seres Therapeutics, Inc. is a leading microbiome therapeutics company developing a novel class of multifunctional bacterial consortia designed to functionally interact with host cells and tissues to treat disease. Seres' SER-109 program achieved the first-ever positive pivotal clinical results for a targeted microbiome drug candidate and has obtained Breakthrough Therapy and Orphan Drug designations from the FDA. The SER-109 program is being advanced for the treatment of recurrent C. difficile infection and has potential to become a first-in-class FDA-approved microbiome therapeutic. Seres is evaluating SER-301 in a Phase 1b study in patients with ulcerative colitis and SER-155 in a Phase 1b study to address gastrointestinal infections, bacteremia and graft-versus-host disease. For more information, please visit https://www.serestherapeutics.com.

About C Diff Foundation:

C Diff Foundation, a 501(c)(3) nonprofit, is the leading patient and healthcare organization educating and advocating for C. difficile (Clostridioides difficile, C. diff., CDI, CDAD) prevention, treatments, clinical trials, diagnostics, support, and environmental safety worldwide. Their Mission continues to move forward and grow through research conducted by government, industry, and academia strengthening the advocacy on behalf of patients, families, caregivers, healthcare professionals, and researchers worldwide. For more information: https://cdifffoundation.org/

Follow C Diff Foundation:

Twitter @cdiffFoundation

#cdiffwalks2021 #cdiff2021

C Diff Foundation(tm) is a trademark of C Diff Foundation, established 2012 in the U.S.

MEDIA CONTACT:

Kathy Bischoff, Global Walk Committee

kathy@cdifffoundation.org

(727) 205-3922

MULTIMEDIA:

IMAGE link for media: https://www.Send2Press.com/300dpi/21-0920s2p-cdf-events-300dpi.jpg

Related link: https://cdifffoundation.org/

This news story was published by the Neotrope® News Network - all rights reserved.

Business, Free News Articles, NonProfit and Charities, Regional Events

C Diff Foundation Hosts 3rd Annual Global C.diff. Awareness 2K Walks

TEANECK, N.J. -- C Diff Foundation announced today that registration is now open for the 3rd Annual Global C.diff. Awareness 2K Walks. The events, which will take place at the Morris A. Votee Park, Teaneck, N.J., Charlestown Township Park, Phoenixville, Pa., and Sims Park, New Port Richey, Fla., will be hosted by the C Diff Foundation on Saturday, May 18, 2019 from 8 a.m. - 12 p.m.

Dr. Martha Cloakie, PhD will be leading the walk in Leicester, U.K. on Friday, May 17, 2019.

All registered awareness walkers will receive t-shirts, giveaways, and educational material while introducing the communities to the resources available. C.diff. infections are one of the leading healthcare-associated infections facing local communities.

Registration is $20.00 per walker and children 10 years of age and under walk free. https://cdifffoundation.org/3rdannualwalk/

Proceeds from the events will benefit the C Diff Foundation's mission educating and advocating for C.difficile infection prevention, treatments, clinical trials, and environmental safety worldwide.

According to the Centers for Disease Control and Prevention (CDC), a Clostridioides difficile infection (C.difficile), (formally known as Clostridium difficile) "has become the most common microbial cause of healthcare-associated infections in U.S. hospitals and costs up to $4.8 billion each year in excess health care costs for acute care facilities alone."

Statistics provided by the CDC suggest that C. difficile cause nearly 500,000 infections in patients in the U.S. annually. In one study noted by the CDC, among infected patients, nearly 29,000 died within 30 days of being diagnosed, and more than half of those deaths (15,000) were directly attributable to a C. difficile infection.

"Every day the C Diff Foundation members work to educate and advocate for C. difficile infection prevention, treatments, clinical trials, and environmental safety while providing support worldwide. Our dedication to the cause is making a difference as we share a common goal with government agencies and health care organizations witnessing a decrease in newly diagnosed C.diff. infections and saving lives. Our dedicated volunteering members, around the globe, are focused on improving the lives of individuals and families who are impacted by C.diff. infections," says Nancy Caralla, Founding President, and Executive Director of the C Diff Foundation.

We sincerely thank Vedanta Biosciences, Inc. for being the Diamond Sponsor of the 3rd Annual Global C.diff. Awareness 2K Walks. Vedanta Biosciences, Inc. is dedicated to finding treatments for patients with serious infections and immune diseases. Vedanta develops medicines made of consortia of bacterial strains which are selected to effect robust and durable changes in a patient's gut microbiota.

In contrast to fecal transplants or administration of fecal fractions, Vedanta's medicines are pure, uniform compositions of bacteria manufactured from clonal cell banks, bypassing the need to rely on direct sourcing of fecal donor material of inconsistent composition. Vedanta is currently enrolling patients with recurrent C. difficile infections (CDI) in its CONSORTIUM study to evaluate VE303, an investigational treatment for CDI.

About the C Diff Foundation:

The C Diff Foundation, a 501(c)(3) supports public health through educating and advocating for C. difficile infection prevention, treatments, clinical trials, and environmental safety worldwide. For more information, or to find out how you can be a host of a Global C.diff. Awareness 2K Walk visit http://www.cdifffoundation.org.

Follow C Diff Foundation on Twitter
@cdiffFoundation
#CdiffWalk2019

Related link:

This news story was published by the Neotrope® News Network - all rights reserved.

Free News Articles, Hospitals and Nursing, NonProfit and Charities, Regional Events

2nd Annual Global C.diff. Walks in US and UK to Raise Awareness on Importance of Clostridium difficile Infections Worldwide

TEANECK, N.J. -- Presented by the C Diff Foundation, the 2nd Annual Global C.diff. Awareness 2K Walks will take place on Saturday, May 19 at three separate locations: Morris A. Votee Park, Teaneck, New Jersey; Sims Park, New Port Richey, Florida; and in Leicester, England. All locations will include t-shirts and resourceful educational material for all registered walkers. The U.S. locations will also include water bottles and hydration stations.

According to the Centers for Disease Control and Prevention (CDC), Clostridium difficile infection (C. difficile) "has become the most common microbial cause of healthcare-associated infections in U.S. hospitals and costs up to $4.8 billion each year in excess health care costs for acute care facilities alone." Statistics provided by the CDC suggest that C. difficile cause nearly 500,000 infections in patients in the U.S. annually. In one study noted by the CDC, among infected patients, nearly 29,000 died within 30 days of being diagnosed, and more than half of those deaths (15,000) were directly attributable to a C. difficile infection.

The Global C. diff. Walks will raise awareness of

Clostridium difficile (C. diff.) infection prevention and provide educational material while introducing the communities to the resources available. C.diff. infections are one of the leading health issues facing local communities.

"Every day the C Diff Foundation works to educate and advocate for C. difficile infection prevention, treatments, environmental safety and support worldwide to save lives. Our dedicated volunteering members are focused on improving the lives of individuals and families that are impacted by a C.diff. infection," says Nancy Caralla, Founding President of the C Diff Foundation.

We sincerely thank the following Sponsors for their continued support and for joining the C Diff Foundation in promoting
C. diff. Awareness worldwide:
Platinum: CutisPharma, Inc.
Gold: Pfizer and Xenex Disinfection Services.
Silver: Quellthera.

Event Details:
When: Saturday, May 19, 2018 - "rain or shine."

Registration and Check-in takes place at 8 a.m. Walk and Program begins at 9 a.m. at: Milton A. Votee Park, Queen Anne Rd & Court St, Teaneck, NJ 07666; Sims Park, 6341 Bank Street, New Port Richey, FL 34652; and being led by Dr. Martha Cloakie, PhD, a walk in the park in Leicester, England.

To register on-line: https://cdifffoundation.org/ or https://cdifffoundation.org/2nd-annual-global-walks-2018/

Walkers can register individually ($20 per person) or as a team ($20 for team leader) and teams can recruit sponsors.

All proceeds raised will support the program of the C Diff Foundation which provides villages to cities with C. difficile infection education, advocacy, and support worldwide.

For additional information about the walk, please email info@cdifffoundation.org or call the main office in U.S.: (919) 201-1512.

About the C Diff Foundation:

The C Diff Foundation, a 501(c)(3) established 2012, comprised of 100 percent volunteering professionals who are dedicated supporting public health through education and advocating for C. difficile infection (CDI) prevention, treatments, environmental safety, and support worldwide.

Follow C Diff Foundation on Twitter
@cdiffFoundation
#CdiffWalk2018

Media Contact:
Angelo Ortiz, Global Walk Committee
angelo.ortiz@cdifffoundation.org

Related link:

This news story was published by the Neotrope® News Network - all rights reserved.